Researchers Uncover How Common Gut Bacteria Triggers Colon Cancer, Design Blocking Therapy
Researchers have solved a longstanding mystery surrounding how certain gut bacteria may contribute to colorectal cancer development. A team has identified the specific mechanism by which a bacterial toxin associated with colorectal cancer attacks the colon's protective barrier.
The toxin was found to first bind to a receptor called claudin-4, which grants it access to damage the cells protecting the colon lining. This binding mechanism represents a critical weak point in the pathogen's attack strategy.
Using this knowledge, researchers designed a decoy protein engineered to intercept the toxin before it can bind to claudin-4. In mouse models, this decoy protein successfully blocked the toxin's harmful effects.
The discovery opens potential pathways for developing new preventive therapies targeting inflammation and tumor formation in the colon. Future research will focus on translating these findings from mouse models to human applications.